LOTTE Holdings, Co., Ltd. (Tokyo, Japan; CEO: Genichi Tamatsuka, hereinafter “LOTTE Holdings”) announces an investment in Alveus Therapeutics, Inc. (hereinafter “Alveus Therapeutics”), a rapidly ...
The companies have identified an initial set of genetic biomarkers to predict drug response and will validate the findings in ...
Biomed Industries, Inc. Presented Breakthrough Unified Theory Linking Alzheimer’s Disease, Obesity and Cardiovascular ...
It's 'definitely not a measure of fatness,' and it doesn't accurately define what it means to be overweight. Body mass index isn't always the best predictor of health. In the age of weight-loss drugs, ...
Researchers found that the risk of type 2 diabetes varies among young adults. Those with high fasting glucose who qualified ...
Experts from leading obesity organizations have published recommendations affirming the effectiveness, safety and ...
Week Study to Evaluate One-Step Dose Titration to 48 mg and Two-Step Dose Titration to 64 mg in Obese Otherwise Healthy Adults CAMBRIDGE, Mass., March 18, 2026 ...
The lowered pricing structure is now available for 101.82 EUR per bottle at pharmacies throughout Finland AMSTERDAM, March 18, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharma ...
A research team affiliated with UNIST has made a significant discovery explaining why liver cancers associated with obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results